美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

美國抗疫概念

1,410.86

+30.122.18%

漲家數：15

跌家數：4

平家數：- -

市盈率：- -

高：1,411.87

開：1,380.80

低：1,380.80

收：1,380.73

資料載入中...

吉利德簽署lenacapavir使用權協議；Arvinas首席執行官將卸任Gilead signs lenacapavir access deal; Arvinas CEO to step down

伊諾維奧製藥盤中異動股價大漲5.22%報1.41美元

強生公司在與Viatris和梯瓦製藥的專利糾紛中勝訴

环球市场播报

Equillium, Inc.盤中異動股價大漲5.77%

Ocugen, Inc.盤中異動股價大漲5.24%報1.11美元

Vir Biotechnology, Inc.盤中異動股價大漲5.09%報5.57美元

吉利德公司與全球基金敲定向貧困國家供應艾滋病預防藥物的計劃

10億美元收購後，阿斯利康體內CAR-T療法首戰告捷

輝瑞7月8日成交額為13.13億美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4568/news?page=11"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美國抗疫概念","latestPrice":1410.855,"timestamp":1753214399999,"preClose":1380.7327,"halted":0,"volume":94242549,"delay":0,"changeRate":0.021816,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":30.122314,"latestTime":"07-22 16:00:00 EDT","open":1380.801,"high":1411.8705,"low":1380.8005,"amount":4720359342.360147,"amplitude":0.022503,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1753257600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.661764,"peRate":21.252439,"turnoverRate":0.006157,"increases":15,"decrements":4,"flats":0,"marketCap":1163686913687.5,"floatMarketCap":1142651189596.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1411.8705,"amplitude":0.022503,"preClose":1380.7327,"low":1380.8005,"pbRate":"3.661764","latestPrice":1410.855,"volume":94242549,"delay":0,"open":1380.801,"prevYearClose":1274.8187,"prevWeekClose":1379.0648,"prevMonthClose":1377.5769,"prevQuarterClose":1377.5769,"fiveDayClose":1378.7249,"twentyDayClose":1360.6882,"sixtyDayClose":1349.2345,"secType":"PLATE","market":"US","turnoverRate":0.006157,"peRate":21.252439,"marketCap":1163686913687.5,"floatMarketCap":1142651189596.5,"timestamp":1753214399999,"nameCN":"美國抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":15,"down":4,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:11,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2550510496","title":"吉利德簽署lenacapavir使用權協議；Arvinas首席執行官將卸任Gilead signs lenacapavir access deal; Arvinas CEO to step down","url":"https://stock-news.laohu8.com/highlight/detail?id=2550510496","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550510496?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 23:38","pubTimestamp":1752075480,"startTime":"0","endTime":"0","summary":"The Global Fund will prioritize country access based on HIV epidemiology and available resources. The move builds on previous steps taken by Gilead, including its agreement in October to license rights to manufacture and supply lenacapavir in many of these countries. The new deal will provide enough doses for up to 2 million people to access the drug until those licensed generic versions are available.全球基金将根据艾滋病流行病学和可用资源优先考虑各国的获取机会。— Delilah Alvarado— 德利拉·阿尔瓦拉多Arvinas阿文纳斯CEO首席执行官John Houston约翰·休斯顿will step down following the search and appointment of a new CEO将在新任首席执行官的搜寻和任命后卸任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709233911953c50da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709233911953c50da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0234570918.USD","BK4583","LU2468319806.SGD","LU2087621335.USD","LU1778281490.HKD","IE00BSNM7G36.USD","LU1066053197.SGD","SG9999015978.USD","IE00B3T34201.USD","BK4588","SG9999015952.SGD","IE00B7SZLL34.SGD","IE00BKVL7J92.USD","LU0823416689.USD","BK4532","SG9999015945.SGD","IE0002270589.USD","LU1674673691.USD","LU2324357040.USD","LU1839511570.USD","BK4578","LU0109394709.USD","LU1585245621.USD","IE00B19Z3B42.SGD","LU1066051498.USD","BK4566","GILD","SG9999015986.USD","LU0058720904.USD","LU1674673428.USD","BK4550","LU0289739699.SGD","BK4585","LU0889565916.HKD","BK4568","BK4139","LU1571399168.USD","IE00BZ1G4Q59.USD","LU0320765992.SGD","LU1430594728.SGD","LU2089984988.USD","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2550565953","title":"伊諾維奧製藥盤中異動 股價大漲5.22%報1.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550565953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550565953?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 23:03","pubTimestamp":1752073432,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日23时03分，伊诺维奥制药股票出现波动，股价快速上涨5.22%。截至发稿，该股报1.41美元/股，成交量167.455万股，换手率3.29%，振幅4.48%。伊诺维奥制药股票所在的生物技术行业中，整体涨幅为1.37%。伊诺维奥制药公司简介：Inovio Pharmaceuticals Inc 是一家总部位于美国的生物技术公司。该公司专注于开发和商业化 DNA 药物，以帮助治疗和保护人们免受 HPV 相关疾病、癌症和传染病的侵害。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709230352953c49ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709230352953c49ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","INO","BK4139","BK4583"],"gpt_icon":0},{"id":"2550022656","title":"強生公司在與Viatris和梯瓦製藥的專利糾紛中勝訴","url":"https://stock-news.laohu8.com/highlight/detail?id=2550022656","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550022656?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 22:58","pubTimestamp":1752073080,"startTime":"0","endTime":"0","summary":"美国联邦巡回上诉法院周二裁定，支持强生公司在与Viatris和梯瓦制药关于神经科药物Invega Sustenna的专利纠纷中的立场。　　法院认定Viatris和梯瓦制药未能证明Invega Sustenna相关专利创新是显而易见的，这一裁决将阻止两家公司在美国推出该药物的仿制版本。法院综合考虑了梯瓦和Viatris提出的所有反对论点。　　强生的Invega系列药物用于治疗成人精神分裂症，2024年在美销售额达31亿美元，同比增长约8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-07-09/doc-infewyzf2415110.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00BGHQF631.EUR","LU1244550494.USD","LU1023059063.AUD","JNJ","LU1244550221.USD","LU0345770308.USD","BK4504","LU2347655156.SGD","LU0889566641.SGD","LU2592432038.USD","BK4568","IE00BJJMRZ35.SGD","LU1057294990.SGD","LU0203347892.USD","LU1280957306.USD","BK4584","LU1196500208.SGD","LU1221951129.SGD","LU0882574055.USD","LU1032955483.USD","LU1244550577.SGD","LU1732800096.USD","LU2112291526.USD","BK4532","LU0098860793.USD","LU1221951046.USD","LU1506573853.SGD","BK4007","LU2129689514.USD","IE00BJT1NW94.SGD","IE0002270589.USD","LU0234570918.USD","IE00BFXG1179.USD","LU1894683348.USD","LU2505996681.GBP","LU1074936037.SGD","LU0289739699.SGD","BK4585","LU1267930813.SGD","LU1061106388.HKD","LU2602419157.SGD","TEVA","LU1066053197.SGD","BK4559","IE00BBT3K403.USD","IE00B19Z3B42.SGD","SG9999002224.SGD","LU0640476718.USD","IE00B3T34201.USD","IE00BLSP4239.USD"],"gpt_icon":0},{"id":"2550655700","title":"Equillium, Inc.盤中異動 股價大漲5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550655700","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550655700?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 22:12","pubTimestamp":1752070376,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时12分，Equillium, Inc.股票出现异动，股价大幅上涨5.77%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为1.31%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709221256953c3e7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709221256953c3e7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EQ","BK4568","BK4139"],"gpt_icon":0},{"id":"2550765556","title":"Ocugen, Inc.盤中異動 股價大漲5.24%報1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550765556","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550765556?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 21:50","pubTimestamp":1752069048,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时50分，Ocugen, Inc.股票出现异动，股价大幅上涨5.24%。截至发稿，该股报1.11美元/股，成交量82.3154万股，换手率0.28%，振幅3.81%。Ocugen, Inc.股票所在的生物技术行业中，整体涨幅为1.00%。Ocugen, Inc.公司简介：Ocugen Inc 公司专注于发现、开发和商业化新型基因和细胞疗法和疫苗，以改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709215048a69f9456&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709215048a69f9456&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","OCGN","BK4139","BK4568"],"gpt_icon":0},{"id":"2550653515","title":"Vir Biotechnology, Inc.盤中異動 股價大漲5.09%報5.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550653515","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550653515?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 21:38","pubTimestamp":1752068321,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时38分，Vir Biotechnology, Inc.股票出现异动，股价急速拉升5.09%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为1.18%。其相关个股中，Calidi Biotherapeutics, Inc.、Prokidney Corp.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Calidi Biotherapeutics, Inc.、Kazia Therapeutics Limited、Mustang Bio, Inc.较为活跃，换手率分别为629.20%、541.66%、401.21%，振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Prokidney Corp.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为56.72%、23.86%、19.80%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709213841979fb72c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709213841979fb72c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","VIR","BK4535","BK4139","BK4585"],"gpt_icon":0},{"id":"2550632561","title":"吉利德公司與全球基金敲定向貧困國家供應艾滋病預防藥物的計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=2550632561","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550632561?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 20:00","pubTimestamp":1752062416,"startTime":"0","endTime":"0","summary":"吉利德公司与全球基金敲定向贫困国家供应艾滋病预防药物的计划吉利德公司将在三年内为 200 万人提供来那卡韦，费用自理全球基金根据艾滋病发病率确定优先获取权，重点关注撒哈拉以南非洲地区吉利德公司首席执行官对美国未来为全球艾滋病项目提供资金充满希望Deena Beasley/Jennifer Rigby","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nL4S3T60YC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","IE00B7SZLL34.SGD","BK4585","LU0823416689.USD","LU0234570918.USD","LU0058720904.USD","IE00BZ1G4Q59.USD","IE00B19Z3B42.SGD","GILD","LU0320765992.SGD","LU1066053197.SGD","LU1571399168.USD","LU0289739699.SGD","LU1585245621.USD","LU2089984988.USD","LU1066051498.USD","BK4568","IE0002270589.USD","LU1674673428.USD","LU2087621335.USD","IE00BKVL7J92.USD","BK4566","BK4578","SG9999015945.SGD","LU2324357040.USD","BK4139","LU0109394709.USD","LU0889565916.HKD","BK4588","IE00B19Z3581.USD","LU2468319806.SGD","SG9999015986.USD","SG9999015952.SGD","LU1839511570.USD","BK4583","LU1430594728.SGD","LU1674673691.USD","IE00B3T34201.USD","LU1778281490.HKD","IE00BSNM7G36.USD","SG9999015978.USD","BK4532"],"gpt_icon":0},{"id":"2550687533","title":"10億美元收購後，阿斯利康體內CAR-T療法首戰告捷","url":"https://stock-news.laohu8.com/highlight/detail?id=2550687533","media":"药事纵横","labels":["productRelease","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550687533?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 17:00","pubTimestamp":1752051600,"startTime":"0","endTime":"0","summary":"阿斯利康以最高10亿美元收购比利时生物技术公司EsoBiotec仅一个月后，7月7日，其核心资产在研体内CAR-T疗法ESO-T01便在《柳叶刀》披露首组临床数据，为这家传统药企的细胞基因治疗布局注入强心剂。此次收购是阿斯利康深化细胞基因治疗布局的关键一步。随着首个临床数据的公布，这款颠覆性体内CAR-T疗法的后续开发进程，将成为检验传统药企转型创新生物技术领域成效的重要标尺。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709170435a43ff7ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709170435a43ff7ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1829250122.USD","BK4568","BK4588","LU2417539215.USD","BK4230","LU0320765992.SGD","CAR","LU2456880835.USD","BK4585","LU0889565916.HKD","LU2236285917.USD","LU2462157665.USD","LU0109394709.USD","BK4007","AZN","BK4022"],"gpt_icon":0},{"id":"2550748504","title":"輝瑞7月8日成交額為13.13億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550748504","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550748504?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 12:53","pubTimestamp":1752036804,"startTime":"0","endTime":"0","summary":"美东时间2025年7月8日，辉瑞成交额为13.13亿美元，成交额较昨日增加48.78%，当日成交量为5127.58万股。辉瑞于2025年7月8日涨1.51%，报25.62美元，该股过去5个交易日涨5.69%，年初至今涨0.04%，过去60日涨16.09%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-08|13.13亿|48.78%|5127.58万|#|2025-07-07|8.83亿|28.25%|3490.59万|#|2025-07-03|6.88亿|-25.90%|2710.46万|#|2025-07-02|9.29亿|-37.26%|3677.21万|#|2025-07-01|14.81亿|36.50%|5925.99万|辉瑞是世界上最大的制药公司之一，年销售额约为600亿美元。辉瑞在全球销售这些产品，国际销售额占总销售额的40%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709125327a43f7b3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709125327a43f7b3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1883839398.USD","BK4534","LU0058720904.USD","LU0225771236.USD","LU0306806265.USD","LU0321505868.SGD","LU0985481810.HKD","SG9999001176.SGD","IE00BLSP4239.USD","BK4581","LU0306807586.USD","LU0225284248.USD","BK4550","IE00B19Z3581.USD","IE00BBT3K403.USD","LU0321505439.SGD","LU0456855351.SGD","LU1894683264.USD","PFE","LU1023059063.AUD","IE000M9KFDE8.USD","SG9999013999.USD","IE00BLSP4452.SGD","LU1057294990.SGD","BK4592","LU1066053197.SGD","LU1066051498.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU0170899867.USD","LU0289739699.SGD","LU0868494617.USD","LU0122379950.USD","BK4588","SG9999001176.USD","SG9999002232.USD","BK4585","BK4007","BK4568","BK4533","SGXZ57979304.SGD","BK4599","SG9999011175.SGD","LU1894683348.USD","SG9999002224.SGD","LU0234572021.USD","SG9999003800.SGD"],"gpt_icon":1}],"pageSize":20,"totalPage":11,"pageCount":11,"totalSize":209,"code":"91000000","status":"200"}]}}